MedTrace Logo

Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer

NCT00260975 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2017-09-25

No results posted yet for this study

Summary

Many breast cancer patients treated with chemotherapy complain of problems with concentration and memory. This has been referred to as chemo fog. The current study is investigating this phenomenon by measuring mental function of breast cancer patients prior to and after exposure to chemotherapy, and by comparing mental function in those patients who receive chemotherapy and those who do not.

Conditions

Sponsors & Collaborators

  • Canadian Breast Cancer Foundation

    collaborator OTHER

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Barbara Collins · OHRI

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-06-30
Primary Completion
2008-02-29
Completion
2008-02-29

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00260975 on ClinicalTrials.gov